课题基金 / 基金详情

FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS

FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
FAS 和 BC1-2 以及颗粒细胞凋亡
批准号:
6164877
负责人:
NICHOLAS A CATALDO
金额:
$7.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-03-01 至 2001-08-31

项目摘要

项目成果

NICHOLAS A CATALDO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Candidate. The candidate has been trained in obstetrics and gynecology and has completed a subspecialty fellowship in Reproductive Endocrinology. He has been actively engaged in basic research on human granulosa cell physiology for over 4 years and has experience with a number of the techniques to be used in this proposal. He has published five first-author papers, and another has been submitted (Appendix). Research plan. During embryonic and fetal development, the number of oocytes in the human ovary increases until mid-gestation, after which it steadily declines until the menopause. Oocytes which are not surrounded by granulosa cells nearly i ovarian development undergo atresia, while follicles also undergo atresia at every stage of development from the primordial to the tertiary antral stage. The vast majority of oocytes are lost through atresia; only a minority mature to ovulation. In non-human models, atresia of antral follicles has been associated with granulosa cell apoptosis, or programmed cell death. Activation of apoptosis can be regulated by both extracellular (cytokine, growth facto) and intracellular mechanisms. The extracellular factors which regulate non- human granulosa cell apoptosis are being reported. The proposed studies seek to identify the intracellular pathways that signal the human granulosa cell to undergo apoptosis, as well as the source and identity of th extracellular effectors that activate the apoptotic signal through these pathways. A better understanding of the process of granulosa cell apoptosis may aid in the design of new therapies to retard the loss of oocytes that accompanies both normal aging and therapies for malignancy. The specific aims of this proposal are to investigate the roles of the intracellular apoptosis-regulating molecules Fas/APO-1 and Bcl-2 in the human ovary, as well as the roles of the cytokines interferon-gamma (IFN- gamma) and tumor necrosis factor-alpha (TNF-alpha) in transmitting the apoptotic signal. These studies may also help to determine whether the apoptotic signal originates within ovarian parenchymal cells or from leukocytes. It is hypothesized that in human granulosa cells, expression and activation of Fas promotes apoptosis, while Bcl-2 expression in excess of its antagonist Bax prevents apoptosis. It is further hypothesized that IFN-gamma induces Fas expression, while TNF-alpha may induce apoptosis through its own receptor. Environment. The Reproductive Endocrinology Center at the university of California, San Francisco is supported by NIH Grant #HD11979. Included in the Center are Morphology, Molecular Biology, and Radioimmunoassay Cores, the facilities of which are available to the investigator. The Primary Sponsor's laboratory and these Cores contain all of the necessary equipment for the studies proposed.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and -4 accumulation by human luteinizing granulosa cells, and interferon-gamma promotes their apoptosis.
干扰素-γ和激活素A促进人黄体化颗粒细胞的胰岛素样生长因子结合蛋白-2和-4积累,干扰素-γ促进其凋亡。
DOI: 10.1210/jcem.83.1.4481
发表时间: 1998
期刊: The Journal of clinical endocrinology and metabolism.
影响因子: --
作者: [Cataldo,NA, Fujimoto,VY, Jaffe,RB]
通讯作者: Jaffe,RB
DOI: 10.1210/edrv.20.4.0374
发表时间: 1999-08
期刊: Endocrine reviews
影响因子: 20.3
作者: [L. Poretsky;N. Cataldo;Z. Rosenwaks;L. Giudice]
通讯作者: L. Poretsky;N. Cataldo;Z. Rosenwaks;L. Giudice
ROSIGLITAZONE AND CLOMIPHENE FOR OVULATION INDUCTION
  • 批准号:
    7202018
  • 项目类别:
  • 资助金额:
    $0.7万
  • 财政年份:
    2004
  • 负责人:
    NICHOLAS A CATALDO
  • 依托单位:
Troglitazone and Clomiphene for Ovulation Induction
  • 批准号:
    6980889
  • 项目类别:
  • 资助金额:
    $0.95万
  • 财政年份:
    2003
  • 负责人:
    NICHOLAS A CATALDO
  • 依托单位:
Rosiglitazone in Polycystic Ovary Syndrome
  • 批准号:
    6980894
  • 项目类别:
  • 资助金额:
    $7.59万
  • 财政年份:
    2003
  • 负责人:
    NICHOLAS A CATALDO
  • 依托单位:
Rosiglitazone and Clomiphene for Ovulation Induction
  • 批准号:
    6399073
  • 项目类别:
  • 资助金额:
    $6.05万
  • 财政年份:
    2001
  • 负责人:
    NICHOLAS A CATALDO
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: